Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed with the Affinity-Tailored T-Cell-adaptor in Phase I Study

americanpharmaceuticalreviewAugust 01, 2019

Tag: cancer , Affinity-Tailored , T-Cell-adaptor

PharmaSources Customer Service